LegendSince

NQ1! - Pending Sell Stop Hunt

Short
LegendSince Updated   
CME_MINI:NQH2024   E-mini Nasdaq-100 Futures (Mar 2024)
For 10 days, price action for NQ1! has been relatively rangebound with Friday wicking through $18,372.75 all time highs but closing at the $18,040 weekly bullish order block.

$17825.75 is my next short term target with $17,600 being the next take profit target if we are to continue the decline.

My philosophy is simple...

Fortify Michael J Huddlestone's concepts that I have studied to consistently predict where the market is more likely to go.

This includes;

- Market Structure
- Buyside/Sellside Liquidity
- Order Blocks
- Liquidity Voids
- Fair Value Gaps
- Optimal Trade Entry
- Premium/Discount Array
- SIBI/BISI
- Many More!

The strategies mentioned here are some of many that I use to implement into my analysis and over time, with consistency I aim to achieve a high degree of accuracy in the markets with the foresight and understanding to assess what went wrong when my bias is negated.

Credits;

- Michael Joe HUDDLESTONE
- Shawn Lee POWELL
- Toray KORTAN
Trade active:
Throughout the whole of this week, i have been fighting food poisoning with today being the day i was admitted into hospital hence the reason for a delayed update to all of the asset pairs analysed for this weeks trading. But this does not mean abandonment!

Very similar bias to ES, I wanted to see a waterfall for all three indexes; ES, NQ and YM and that’s what Santa delivered this week!

Unlike ES, NQ has been trading within a range for the past month or so with no major break in market structure and daily sell side liquidity unfuffilled.

My first projection for NQ was $18,040, even though market conditions prior wasn’t the best, I figured if we can get through that weekly order block range, $17825.75 is the next point of call which I do believe is a strong possibility looking into next weeks price action.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.